Lauren E Hudson is a Shenandoah, Texas based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Lauren E Hudson is U0130 for Ophthalmology in Texas. Lauren E Hudson is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Lauren E Hudson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Female
Practice Address:
129 Vision Park Blvd Ste 110, Shenandoah, Texas, 77384-3024
Phone:
936-539-4500
Fax:
936-539-4050
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1730685421
NPI Enumeration Date:
02 Apr, 2018
NPI Last Update On:
21 Oct, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Lauren E Hudson are as mentioned below.
License Number
Specialization
State
Status
U0130
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
400 S Loop 336 W, Conroe, Texas
Zip:
77304-3302
Phone Number:
936-539-4500
Fax Number:
936-539-4050
Patients can reach Lauren E Hudson at 129 Vision Park Blvd Ste 110, Shenandoah, Texas or can call to book an appointment on 936-539-4500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.